Details for Patent: 4,758,579

Summary for Patent: 4,758,579

Title:	Fluoroalkoxy substituted benzimidazoles useful as gastric acid secretion inhibitors
Abstract:	Dialkoxypyridines of formula I ##STR1## wherein R1 is 1-3C-alkyl which is completely or predominantly substituted by fluorine, or a chlorodifluoromethyl radical and R1' is hydrogen, halo, trifluoromethyl, 1-3C-alkyl, or 1-3C-alkoxy which is optionally completely or predominantly substituted by fluorine, or R1 and R1', together with the oxygen atom to which R1 is bonded, are 1-2C-alkylenedioxy, which is optionally completely or partly substituted by fluorine, or chlorotrifluoroethylenedioxy, R3 is 1-3C-alkoxy, one of R2 and R4 is 1-3C-alkoxy and the other is a hydrogen atom or 1-3C-alkyl and n is 0 or 1, and salts thereof are new compounds with a pronounced protective action on the stomach. Processes for preparing these compounds, medicaments containing them and their use, as well as intermediate compounds and their use for preparing the subject dialkoxypyridines, are disclosed.
Inventor(s):	Kohl; Bernhard (Konstanz, DE), Sturm; Ernst (Konstanz, DE), Rainer; Georg (Konstanz, DE)
Assignee:	BYK Gulden Lomberg Chemische Fabrik GmbH (Konstanz, DE)
Application Number:	07/045,799
Patent Claim Types: see list of patent claims	Compound; Composition; Use;

Drugs Protected by US Patent 4,758,579

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 4,758,579

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Switzerland	2899/84	Jun 16, 1984
Switzerland	2901/84	Jun 16, 1984

International Family Members for US Patent 4,758,579

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	45737
Australia	4364085
Australia	578703